<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32823486</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>13</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>A Single Mutation in the VP1 Gene of Enterovirus 71 Enhances Viral Binding to Heparan Sulfate and Impairs Viral Pathogenicity in Mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">883</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v12080883</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is the major causative pathogen of human hand, foot, and mouth disease (hHFMD) and has evolved to use various cellular receptors for infection. However, the relationship between receptor preference and EV71 virulence has not been fully revealed. By using reverse genetics, we identified that a single E98K mutation in VP1 is responsible for rapid viral replication in vitro. The E98K mutation enhanced binding of EV71-GZCII to cells in a heparan sulfate (HS)-dependent manner, and it attenuated the virulence of EV71-GZCII in BALB/c mice, indicating that the HS-binding property is negatively associated with viral virulence. HS is widely expressed in vascular endothelial cells in different mouse tissues, and weak colocalization of HS with scavenger receptor B2 (SCARB2) was detected. The cGZCII-98K virus bound more efficiently to mouse tissue homogenates, and the cGZCII-98K virus titers in mouse tissues and blood were much lower than the cGZCII virus titers. Together, these findings suggest that the enhanced adsorption of the cGZCII-98K virus, which likely occurs through HS, is unable to support the efficient replication of EV71 in vivo. Our study confirmed the role of HS-binding sites in EV71 infection and highlighted the importance of the HS receptor in EV71 pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Xianliang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Joint Center of Translational Precision Medicine, Guangzhou Institute of Pediatrics, Guangzhou Women and Children'ss Medical Center, Guangzhou 510623, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Joint Center of Translational Precision Medicine, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Yuanjiu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Caishang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jianhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Qinxue</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-4594-9215</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 511483, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hanzhong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhenhua</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-4117-9364</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9050-30-0</RegistryNumber><NameOfSubstance UI="D006497">Heparitin Sulfate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006497" MajorTopicYN="N">Heparitin Sulfate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="Y">Virus Attachment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VP1-98</Keyword><Keyword MajorTopicYN="N">adaptive mutation</Keyword><Keyword MajorTopicYN="N">attenuation</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">heparan sulfate</Keyword><Keyword MajorTopicYN="N">virulence</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32823486</ArticleId><ArticleId IdType="pmc">PMC7472116</ArticleId><ArticleId IdType="doi">10.3390/v12080883</ArticleId><ArticleId IdType="pii">v12080883</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yi E.J., Shin Y.J., Kim J.H., Kim T.G., Chang S.Y. Enterovirus 71 infection and vaccines. Clin. Exp. Vaccine Res. 2017;6:4&#x2013;14. doi: 10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Rossmann M.G. The cellular receptor for enterovirus 71. Protein Cell. 2014;5:655&#x2013;657. doi: 10.1007/s13238-014-0092-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0092-6</ArticleId><ArticleId IdType="pmc">PMC4145082</ArticleId><ArticleId IdType="pubmed">25103897</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Fujii K., Koike S. Receptors for enterovirus 71. Emerg. Microbes Infect. 2014;3:e53. doi: 10.1038/emi.2014.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.49</ArticleId><ArticleId IdType="pmc">PMC4126179</ArticleId><ArticleId IdType="pubmed">26038749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Ohka S., Fujii K., Koike S. Functional Comparison of SCARB2 and PSGL1 as Receptors for Enterovirus 71. J. Virol. 2013;87:3335&#x2013;3347. doi: 10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.W., Lin H.Y., Tsou Y.L., Chitra E., Hsiao K.N., Shao H.Y., Liu C.C., Sia C., Chong P., Chow Y.H. Human SCARB2-Mediated Entry and Endocytosis of EV71. PLoS ONE. 2012;7:e30507. doi: 10.1371/journal.pone.0030507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030507</ArticleId><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 2009;15:794&#x2013;797. doi: 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S.L., Chou Y.T., Wu C.N., Ho M.S. Annexin II Binds to Capsid Protein VP1 of Enterovirus 71 and Enhances Viral Infectivity. J. Virol. 2011;85:11809&#x2013;11820. doi: 10.1128/JVI.00297-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P.Y., Wang Y.F., Huang S.W., Lo Y.C., Wang Y.H., Wu S.R., Shieh D.B., Chen S.H., Wang J.R., Lai M.D., et al. Cell Surface Nucleolin Facilitates Enterovirus 71 Binding and Infection. J. Virol. 2015;89:4527&#x2013;4538. doi: 10.1128/JVI.03498-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N., Cong H., Tian H., Zhang H., Zhang W., Song L., Tien P. Cell Surface Vimentin Is an Attachment Receptor for Enterovirus 71. J. Virol. 2014;88:5816&#x2013;5833. doi: 10.1128/JVI.03826-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q.Q., Ren S., Xia Z.C., Cheng Z.K., Peng N.F., Zhu Y. Fibronectin Facilitates Enterovirus 71 Infection by Mediating Viral Entry. J. Virol. 2018;92 doi: 10.1128/JVI.02251-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02251-17</ArticleId><ArticleId IdType="pmc">PMC5899198</ArticleId><ArticleId IdType="pubmed">29467312</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Poh C.L., Sam I.C., Chan Y.F. Enterovirus 71 Uses Cell Surface Heparan Sulfate Glycosaminoglycan as an Attachment Receptor. J. Virol. 2013;87:611&#x2013;620. doi: 10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Ma S., Zhu L., Huang Z., Chen L., Xu Y., Yin H., Peng T., Wang Y. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model. Antivir. Res. 2017;137:67&#x2013;75. doi: 10.1016/j.antiviral.2016.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.11.008</ArticleId><ArticleId IdType="pubmed">27864074</ArticleId></ArticleIdList></Reference><Reference><Citation>Victorio C.B.L., Xu Y., Ng Q., Meng T., Chow V.T., Chua K.B. Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain) Emerg. Microbes Infect. 2016;5:1&#x2013;14. doi: 10.1038/emi.2016.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2016.56</ArticleId><ArticleId IdType="pmc">PMC4932649</ArticleId><ArticleId IdType="pubmed">27329847</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Sam I.C., Lee V.S., Wong H.V., Chan Y.F. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology. 2017;501:79&#x2013;87. doi: 10.1016/j.virol.2016.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka E.D., Sobo K., Stoppini L., Cagno V., Abdul F., Piuz I., Meylan P., Huang S., Constant S., Tapparel C. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog. 2018;14:e1007190. doi: 10.1371/journal.ppat.1007190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine E.A., Moncla L.H., Ronderos M.D., Friedrich T.C., Osorio J.E. A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice. J. Virol. 2016;90:8592&#x2013;8604. doi: 10.1128/JVI.01370-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01370-16</ArticleId><ArticleId IdType="pmc">PMC5021399</ArticleId><ArticleId IdType="pubmed">27440896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee H.K., Tan C.W., Yogarajah T., Lee M.H.P., Chai H.J., Hanapi N.A., Yusof S.R., Ong K.C., Lee V.S., Sam I.C., et al. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice. PLoS Pathog. 2019;15:e1007863. doi: 10.1371/journal.ppat.1007863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007863</ArticleId><ArticleId IdType="pmc">PMC6881073</ArticleId><ArticleId IdType="pubmed">31730673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan M.A. Determination of 50% endpoint titer using a simple formula. World J. Virol. 2016;5:85&#x2013;86. doi: 10.5501/wjv.v5.i2.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v5.i2.85</ArticleId><ArticleId IdType="pmc">PMC4861875</ArticleId><ArticleId IdType="pubmed">27175354</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Shimizu H., Nagata N., Ami Y., Suzaki Y., Sata T., Iwasaki T., Miyamura T. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J. Gen. Virol. 2005;86:1391&#x2013;1401. doi: 10.1099/vir.0.80784-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80784-0</ArticleId><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Heigwer F., Kerr G., Boutros M. E-CRISP: Fast CRISPR target site identification. Nat. Methods. 2014;11:122&#x2013;123. doi: 10.1038/nmeth.2812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2812</ArticleId><ArticleId IdType="pubmed">24481216</ArticleId></ArticleIdList></Reference><Reference><Citation>Too I.H., Yeo H., Sessions O.M., Yan B., Libau E.A., Howe J.L., Lim Z.Q., Suku-Maran S., Ong W.Y., Chua K.B., et al. Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway. Sci. Rep. 2016;6:36983. doi: 10.1038/srep36983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep36983</ArticleId><ArticleId IdType="pmc">PMC5111112</ArticleId><ArticleId IdType="pubmed">27849036</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Wu J., Fang D., Qiu Y., Zou X., Jia X., Yin Y., Shen L., Mao L. Exosomes cloak the virion to transmit Enterovirus 71 non-lytically. Virulence. 2020;11:32&#x2013;38. doi: 10.1080/21505594.2019.1705022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2019.1705022</ArticleId><ArticleId IdType="pmc">PMC6961726</ArticleId><ArticleId IdType="pubmed">31885311</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Koike S. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J. Virol. 2011;85:4937&#x2013;4946. doi: 10.1128/JVI.02358-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.P., Kusche-Gullberg M. Heparan Sulfate: Biosynthesis, Structure, and Function. Int. Rev. Cell Mol. Biol. 2016;325:215&#x2013;273. doi: 10.1016/bs.ircmb.2016.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ircmb.2016.02.009</ArticleId><ArticleId IdType="pubmed">27241222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Sudaka Y., Takashino A., Imura A., Fujii K., Koike S. Amino Acid Variation at VP1-145 of Enterovirus 71 Determines Attachment Receptor Usage and Neurovirulence in Human Scavenger Receptor B2 Transgenic Mice. J. Virol. 2018;92 doi: 10.1128/JVI.00681-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00681-18</ArticleId><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 2009;15:798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z., Phuektes P., McMinn P. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. Virus Res. 2012;167:86&#x2013;96. doi: 10.1016/j.virusres.2012.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.04.009</ArticleId><ArticleId IdType="pubmed">22575826</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.W., Wang Y.F., Yu C.K., Su I.J., Wang J.R. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology. 2012;422:132&#x2013;143. doi: 10.1016/j.virol.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., McMinn P.C. The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 2008;89:1622&#x2013;1632. doi: 10.1099/vir.0.83676-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83676-0</ArticleId><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Zhao Y., Kotecha A., Fry E.E., Kelly J.T., Wang X., Rao Z., Rowlands D.J., Ren J., Stuart D.I. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 2019;4:414&#x2013;419. doi: 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Mizuta K., Koike S. Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation. PLoS Pathog. 2020;16:e1008428. doi: 10.1371/journal.ppat.1008428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008428</ArticleId><ArticleId IdType="pmc">PMC7105141</ArticleId><ArticleId IdType="pubmed">32187235</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K., Sudaka Y., Takashino A., Kobayashi K., Kataoka C., Suzuki T., Iwata-Yoshikawa N., Kotani O., Ami Y., Shimizu H., et al. VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection. J. Virol. 2018;92:e00682-18. doi: 10.1128/JVI.00682-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00682-18</ArticleId><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka C., Suzuki T., Kotani O., Iwata-Yoshikawa N., Nagata N., Ami Y., Wakita T., Nishimura Y., Shimizu H. The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model. PLoS Pathog. 2015;11:e1005033. doi: 10.1371/journal.ppat.1005033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005033</ArticleId><ArticleId IdType="pmc">PMC4504482</ArticleId><ArticleId IdType="pubmed">26181772</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickells J., Cannella M., Droll D.A., Liang Y., Wold W.S.M., Chambers T.J. Neuroadapted Yellow Fever Virus Strain 17D: A Charged Locus in Domain III of the E Protein Governs Heparin Binding Activity and Neuroinvasiveness in the SCID Mouse Model. J. Virol. 2008;82:12510&#x2013;12519. doi: 10.1128/JVI.00458-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00458-08</ArticleId><ArticleId IdType="pmc">PMC2593324</ArticleId><ArticleId IdType="pubmed">18842715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E., Wright P.J., Davidson A., Lobigs M. Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination. J. Gen. Virol. 2006;87:2791&#x2013;2801. doi: 10.1099/vir.0.82164-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82164-0</ArticleId><ArticleId IdType="pubmed">16963737</ArticleId></ArticleIdList></Reference><Reference><Citation>Anez G., Men R.H., Eckels K.H., Lai C.J. Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques. J. Virol. 2009;83:10384&#x2013;10394. doi: 10.1128/JVI.01083-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01083-09</ArticleId><ArticleId IdType="pmc">PMC2753127</ArticleId><ArticleId IdType="pubmed">19656873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E., Hall R.A., Lobigs M. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J. Virol. 2004;78:8271&#x2013;8280. doi: 10.1128/JVI.78.15.8271-8280.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.8271-8280.2004</ArticleId><ArticleId IdType="pmc">PMC446099</ArticleId><ArticleId IdType="pubmed">15254199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashbrook A.W., Burrack K.S., Silva L.A., Montgomery S.A., Heise M.T., Morrison T.E., Dermody T.S. Residue 82 of the Chikungunya Virus E2 Attachment Protein Modulates Viral Dissemination and Arthritis in Mice. J. Virol. 2014;88:12180&#x2013;12192. doi: 10.1128/JVI.01672-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01672-14</ArticleId><ArticleId IdType="pmc">PMC4248890</ArticleId><ArticleId IdType="pubmed">25142598</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L.A., Khomandiak S., Ashbrook A.W., Weller R., Heise M.T., Morrison T.E., Dermody T.S. A Single-Amino-Acid Polymorphism in Chikungunya Virus E2 Glycoprotein Influences Glycosaminoglycan Utilization. J. Virol. 2014;88:2385&#x2013;2397. doi: 10.1128/JVI.03116-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03116-13</ArticleId><ArticleId IdType="pmc">PMC3958064</ArticleId><ArticleId IdType="pubmed">24371059</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner C.L., Hritz J., Sun C.Q., Vanlandingham D.L., Song T.Y., Ghedin E., Higgs S., Klimstra W.B., Ryman K.D. Deliberate Attenuation of Chikungunya Virus by Adaptation to Heparan Sulfate-Dependent Infectivity: A Model for Rational Arboviral Vaccine Design. PLoS Negl. Trop. Dis. 2014;8:e2719. doi: 10.1371/journal.pntd.0002719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002719</ArticleId><ArticleId IdType="pmc">PMC3930508</ArticleId><ArticleId IdType="pubmed">24587470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryman K.D., Klimstra W.B., Johnston R.E. Attenuation of Sindbis virus variants incorporating uncleaved PE2 glycoprotein is correlated with attachment to cell-surface heparan sulfate. Virology. 2004;322:1&#x2013;12. doi: 10.1016/j.virol.2004.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2004.01.003</ArticleId><ArticleId IdType="pubmed">15063111</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard K.A., Klimstra W.B., Johnston R.E. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology. 2000;276:93&#x2013;103. doi: 10.1006/viro.2000.0546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0546</ArticleId><ArticleId IdType="pubmed">11021998</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Pfeiffer J.K. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3. MBio. 2016;7:e00119-16. doi: 10.1128/mBio.00119-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00119-16</ArticleId><ArticleId IdType="pmc">PMC4817249</ArticleId><ArticleId IdType="pubmed">27025249</ArticleId></ArticleIdList></Reference><Reference><Citation>SaCarvalho D., Rieder E., Baxt B., Rodarte R., Tanuri A., Mason P.W. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 1997;71:5115&#x2013;5123. doi: 10.1128/JVI.71.7.5115-5123.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.71.7.5115-5123.1997</ArticleId><ArticleId IdType="pmc">PMC191746</ArticleId><ArticleId IdType="pubmed">9188578</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakkar N., Yadavalli T., Jaishankar D., Shukla D. Emerging Roles of Heparanase in Viral Pathogenesis. Pathogens. 2017;6:43. doi: 10.3390/pathogens6030043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens6030043</ArticleId><ArticleId IdType="pmc">PMC5618000</ArticleId><ArticleId IdType="pubmed">28927006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Wu X., Huang K., Li L., Zheng L., Wan C., He M.L., Zhao W. The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection. BMC Infect. Dis. 2014;14:243. doi: 10.1186/1471-2334-14-243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-243</ArticleId><ArticleId IdType="pmc">PMC4101859</ArticleId><ArticleId IdType="pubmed">24886383</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S.C., Li W.C., Chen G.W., Tsao K.C., Huang C.G., Huang Y.C., Chiu C.H., Kuo C.Y., Tsai K.N., Shih S.R., et al. Genetic characterization of enterovirus 71 isolated from patients with severe disease by comparative analysis of complete genomes. J. Med. Virol. 2012;84:931&#x2013;939. doi: 10.1002/jmv.23287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23287</ArticleId><ArticleId IdType="pubmed">22499017</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Fu C., Wu S., Chen X., Shi Y., Zhou B., Zhang L., Zhang F., Wang Z., Zhang Y., et al. A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China. Virus Genes. 2014;48:260&#x2013;272. doi: 10.1007/s11262-014-1035-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-014-1035-2</ArticleId><ArticleId IdType="pubmed">24442718</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S., Petty T.J., Schibler M., Martinez Y., Gerlach D., van Belle S., Turin L., Zdobnov E., Kaiser L., Tapparel C. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog. 2012;8:e1002826. doi: 10.1371/journal.ppat.1002826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002826</ArticleId><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>